Evolution of the Transforaminal Lumbar Interbody Fusion (TLIF): From Open to Percutaneous to Patient-Specific
- PMID: 38673544
- PMCID: PMC11051479
- DOI: 10.3390/jcm13082271
Evolution of the Transforaminal Lumbar Interbody Fusion (TLIF): From Open to Percutaneous to Patient-Specific
Abstract
The transforaminal lumbar interbody fusion (TLIF) has seen significant evolution since its early inception, reflecting advancements in surgical techniques, patient safety, and outcomes. Originally described as an improvement over the posterior lumbar interbody fusion (PLIF), the TLIF began as an open surgical procedure, that notably reduced the need for the extensive neural retractation that hindered the PLIF. In line with the broader practice of surgery, trending toward minimally invasive access, the TLIF was followed by the development of the minimally invasive TLIF (MIS-TLIF), a technique that further decreased tissue trauma and postoperative complications. Subsequent advancements, including Trans-Kambin's Triangle TLIF (percLIF) and transfacet LIF, have continued to refine surgical access, minimize surgical footprint, and reduce the risk of injury to the patient. The latest evolution, as we will describe it, the patient-specific TLIF, is a culmination of the aforementioned adaptations and incorporates advanced imaging and segmentation technologies into perioperative planning, allowing surgeons to tailor approaches based on individual patient anatomy and pathology. These developments signify a shift towards more precise methods in spine surgery. The ongoing evolution of the TLIF technique illustrates the dynamic nature of surgery and emphasizes the need for continued adaptation and refinement.
Keywords: Kambin’s Triangle; MIS; PLIF; TLIF; neurosegmentation; transfacet.
Conflict of interest statement
Peter N. Drossopoulos: None. Favour C. Ononogbu-uche: None. Troy Q. Tabarestani: None. Chuan-Ching Huang: None. Mounica Paturu: None. Anas Bardeesi: None. Wilson Z. Ray: Royalties: Acera, Depuy, and CoreLink; Consulting: Globus/NuVasive, Depuy, CoreLink; Medical Advisory Board: Globus/NuVasive; Fellowship funding: Medtronic (NREF), Globus (NREF); Grant funding: NIH, Department of Defense, LSRS, Missouri Spinal Cord Injury. Christopher I. Shaffrey: ISSG Foundation, research support; Globus, fellowship support; Medtronic, fellowship support and royalties; NuVasive, fellowship support, royalties and patents, stock options, and consulting; SI Bone, consulting, and royalties; Proprio, consulting; Scoliosis Research Society, board of directors; Cervical Spine Research Society, board of directors. C. Rory Goodwin: Received grants from the Robert Wood Johnson Harold Amos Medical Faculty Development Program, the Federal Food and Drug Administration, Duke Bass Connections, and the NIH 1R01DE031053-01A1. Consultant for Stryker and Medtronic. Deputy Editor for Spine. Patent Application/invention disclosures outside of the current work. Melissa Erickson: None. John H. Chi: Stryker Spine, consulting; Orthofix Spine, consulting. Muhammad M. Abd-El-Barr: Spineology, consultant; Depuy Synthes, consultant; TrackX, consultant; Spinal Elements, consultant; Globus, consultant; BrainLab, consultant; Research support from NIH, AbbVie, and Dana and Christopher Reeve Foundation.
Figures







References
-
- Briggs H.M., Paul R. Chip fusion of the low back following exploration of the spinal canal. J. Bone Jt. Surg. 1944;26:125–130.
Publication types
LinkOut - more resources
Full Text Sources